BIOMAT Database Logo BIOMAT Database Logo

[31P-NMR spectroscopy of the human liver and bile]. 1988

D S Khristianovich, and V I Reshetniak, and A S Loginov, and V E Iushmanov, and M A Tumanian

High-resolution 31P-NMR is used for the estimation of phosphate-containing compounds levels in native bile of healthy subjects and patients with primary biliary liver cirrhosis and also in the liver biopsies of patients with chronic calculous cholecystitis. The results demonstrate the possibilities of rapid comparative estimation of the content of main phosphate-containing compounds in human bile and liver biopsies aimed at clinical diagnosis of liver and bile duct diseases.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008105 Liver Cirrhosis, Biliary FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes. Biliary Cirrhosis,Biliary Cirrhosis, Primary,Biliary Cirrhosis, Secondary,Cholangitis, Chronic Nonsuppurative Destructive,Liver Cirrhosis, Obstructive,Primary Biliary Cholangitis,Biliary Cirrhosis, Primary, 1,Primary Biliary Cirrhosis,Secondary Biliary Cholangitis,Secondary Biliary Cirrhosis,Biliary Cholangitides, Primary,Biliary Cholangitis, Primary,Biliary Cholangitis, Secondary,Cholangitides, Primary Biliary,Cholangitis, Primary Biliary,Cholangitis, Secondary Biliary,Cirrhosis, Biliary,Cirrhosis, Secondary Biliary,Liver Cirrhoses, Biliary,Obstructive Liver Cirrhosis,Primary Biliary Cholangitides,Secondary Biliary Cholangitides
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D010761 Phosphorus Radioisotopes Unstable isotopes of phosphorus that decay or disintegrate emitting radiation. P atoms with atomic weights 28-34 except 31 are radioactive phosphorus isotopes. Radioisotopes, Phosphorus
D002764 Cholecystitis Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases. Empyema, Gallbladder,Gallbladder Inflammation,Empyema, Gall Bladder,Gall Bladder Empyema,Gallbladder Empyema,Inflammation, Gallbladder
D002769 Cholelithiasis Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS). Gallstone Disease,Cholelithiases,Gallstone Diseases
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary

Related Publications

D S Khristianovich, and V I Reshetniak, and A S Loginov, and V E Iushmanov, and M A Tumanian
Reproducibility of human cardiac 31P-NMR spectroscopy.
August 1996, NMR in biomedicine,
D S Khristianovich, and V I Reshetniak, and A S Loginov, and V E Iushmanov, and M A Tumanian
31P NMR spectroscopy of animal brain and human limbs.
January 1983, Acta radiologica. Supplementum,
D S Khristianovich, and V I Reshetniak, and A S Loginov, and V E Iushmanov, and M A Tumanian
Broadband proton decoupling in human 31P NMR spectroscopy.
April 1989, NMR in biomedicine,
D S Khristianovich, and V I Reshetniak, and A S Loginov, and V E Iushmanov, and M A Tumanian
1.5 T in vivo 31P NMR spectroscopy of the human liver using a sectorial resonator.
February 1986, Magnetic resonance in medicine,
D S Khristianovich, and V I Reshetniak, and A S Loginov, and V E Iushmanov, and M A Tumanian
Experimental approaches to image localized human 31P NMR spectroscopy.
July 1989, Magnetic resonance in medicine,
D S Khristianovich, and V I Reshetniak, and A S Loginov, and V E Iushmanov, and M A Tumanian
An NMR phased array for human cardiac 31P spectroscopy.
November 1992, Magnetic resonance in medicine,
D S Khristianovich, and V I Reshetniak, and A S Loginov, and V E Iushmanov, and M A Tumanian
31P NMR spectroscopy of brain and heart.
January 1983, Advances in experimental medicine and biology,
D S Khristianovich, and V I Reshetniak, and A S Loginov, and V E Iushmanov, and M A Tumanian
Non-invasive investigation of parenchymal liver disease using 31P NMR spectroscopy.
January 1993, NMR in biomedicine,
D S Khristianovich, and V I Reshetniak, and A S Loginov, and V E Iushmanov, and M A Tumanian
31P magnetic resonance spectroscopy of the human paediatric liver.
April 1990, NMR in biomedicine,
D S Khristianovich, and V I Reshetniak, and A S Loginov, and V E Iushmanov, and M A Tumanian
Methods in 31P and 1H NMR spectroscopy.
September 1987, Therapie,
Copied contents to your clipboard!